Cite
Cancer therapeutic antibodies come of age: Targeting minimal residual disease
MLA
Ben-Kasus, Tsipi, et al. “Cancer Therapeutic Antibodies Come of Age: Targeting Minimal Residual Disease.” Molecular Oncology, vol. 1, no. 1, June 2007, pp. 42–54. EBSCOhost, https://doi.org/10.1016/j.molonc.2007.01.003.
APA
Ben-Kasus, T., Schechter, B., Sela, M., & Yarden, Y. (2007). Cancer therapeutic antibodies come of age: Targeting minimal residual disease. Molecular Oncology, 1(1), 42–54. https://doi.org/10.1016/j.molonc.2007.01.003
Chicago
Ben-Kasus, Tsipi, Bilha Schechter, Michael Sela, and Yosef Yarden. 2007. “Cancer Therapeutic Antibodies Come of Age: Targeting Minimal Residual Disease.” Molecular Oncology 1 (1): 42–54. doi:10.1016/j.molonc.2007.01.003.